Geographic Atrophy Long-Terms Outcomes Study

NCT06499571 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 255

Last updated 2024-07-12

No results posted yet for this study

Summary

The purpose of this study is to describe functional and long-term clinical outcomes of patients with a diagnosis of Geographic Athrophy secondary to Age related Macular Degenaration in Clinical Practice

Conditions

Sponsors & Collaborators

  • Iqvia Pty Ltd

    collaborator INDUSTRY
  • Apellis Pharmaceuticals, Inc.

    lead INDUSTRY

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-07-31
Completion
2023-07-31

Countries

  • Australia
  • France
  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06499571 on ClinicalTrials.gov